See up to 3 months of PGEN. The 7-day demo opens the 1M and 3M ranges and puts PGEN on your watchlist.
Start 7-day demoLatest PGEN insider trades
About PRECIGEN, INC. (PGEN)
The SEC lists PRECIGEN, INC. under CIK 0001356090, in pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
PGEN Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 1 | 3,411 | $25K |
| Open-market sale | 7 | 480,677 | $3.40M |
| Option exercise | 26 | 525,286 | |
PGEN insider transactions (Form 4)
1168 Form 4 filings on record, the earliest from Dec 30, 2024, newest first. Filing history page 3 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Harry Thomasian Jr. - Officer | Grant or award | Performance Stock Units | 125,000 | $0.00 | - | |
| Grant or award | Performance Stock Units | 54,000 | $0.00 | - | ||
| Phil Tennant - Officer | Grant or award | Performance Stock Units | 25,000 | $0.00 | - | |
| Grant or award | Performance Stock Units | 125,000 | $0.00 | - | ||
| Nancy H. Agee - Director | Open-market purchase | Common Stock | 15,000 | $4.60 | $69K | |
| Nancy H. Agee - Director | Open-market purchase | Common Stock | 15,360 | $3.20 | $49K | |
| Nancy H. Agee - Director | Open-market purchase | Common Stock | 10,645 | $4.65 | $49K | |
| Nancy H. Agee - Director | Option exercise | Common Stock | 126,760 | - | - | |
| Nancy H. Agee - Director | Option exercise | Restricted Stock Units | 126,760 | $0.00 | - | |
| Open-market purchase | 8.00% Series A Convertible Perpetual Preferred Stock | 25,000 | - | - | ||
| Open-market purchase | Warrant to Purchase Common Stock | 16,666,667 | - | - |
Recent PGEN Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Jeffrey Kindler | Director | 185,000 | $1.37M | View on EDGAR | |
| Tennant Phil | Officer | 79,166 | $594K |
PGEN insider trading FAQ
What is the latest insider trade for PGEN?
PRECIGEN, INC. (PGEN) had 11 insider filings in the last 90 days, with the most recent on 2026-09-24. The full record for PGEN runs to 68 Form 4 filings, the earliest from 2024-12-30. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying PGEN stock?
1 insider purchase of PGEN was filed in the last 90 days, totaling $25K.
How many insiders are selling PGEN stock?
7 insider sales of PGEN were filed in the last 90 days, totaling $3.40M.
Where can I see PGEN SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects PGEN Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Harry Thomasian Jr. view on EDGAR
- - Jeffrey B. Kindler view on EDGAR
- - Nancy H. Agee view on EDGAR
- - Donald P. Lehr view on EDGAR
- - Harry Thomasian Jr. view on EDGAR
- - Rutul R. Shah view on EDGAR
- - Phil Tennant view on EDGAR
- - Helen Sabzevari view on EDGAR
- - Rutul R. Shah view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where PGEN's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow PGEN with a 7-day demo
- PGEN on your watchlist
- Every PGEN Form 4 filing on record
- Up to 3 months of PGEN price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive